• Explore /
  • Poster
  • / Metformin for chemoprevention of lung cancer in high-risk overweight or obese individuals.

Metformin for chemoprevention of lung cancer in high-risk overweight or obese individuals.

Abstract Poster

Authors

null

Isra Nour

Northwestern University, Chicago, IL

Isra Nour , Stephen Lam , Robert L. Keith , Joseph Barbi , Masha Kocherginsky , Kelly Benante , Tia Schering , Yanfei Xu , Kiril Kalinichenko , Eva Szabo , Lisa Bengtson , Seema Ahsan Khan , Saikrishna S. Yendamuri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Prevention

Clinical Trial Registration Number

NCT04931017

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS10636)

DOI

10.1200/JCO.2023.41.16_suppl.TPS10636

Abstract #

TPS10636

Poster Bd #

269a

Abstract Disclosures

Similar Posters

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

TH1/17 hybrid CD4+ cells in bronchial alveolar lavage fluid from leukemia patients with checkpoint inhibitor-induced pneumonitis.

TH1/17 hybrid CD4+ cells in bronchial alveolar lavage fluid from leukemia patients with checkpoint inhibitor-induced pneumonitis.

First Author: Sang Kim

First Author: Julia Vinagolu-Baur

First Author: Girish S. Kulkarni

First Author: Zongren Wang